220 related articles for article (PubMed ID: 29180242)
21. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
[TBL] [Abstract][Full Text] [Related]
22. Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.
Saito B; Fukuda T; Yokoyama H; Kurosawa S; Takahashi T; Fuji S; Takahashi N; Tajima K; Kim SW; Mori SI; Tanosaki R; Takaue Y; Heike Y
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1148-1155. PubMed ID: 18804045
[TBL] [Abstract][Full Text] [Related]
23. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction.
Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC
J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676
[TBL] [Abstract][Full Text] [Related]
25. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
[TBL] [Abstract][Full Text] [Related]
26. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
[TBL] [Abstract][Full Text] [Related]
27. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
28. Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation.
Waterhouse M; Pfeifer D; Follo M; Duyster J; Schäfer H; Bertz H; Finke J
Clin Chem Lab Med; 2017 Jul; 55(8):1115-1121. PubMed ID: 28099121
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation.
Schaap N; Schattenberg A; Mensink E; Preijers F; Hillegers M; Knops R; Pennings A; Boezeman J; Geurts van Kessel A; de Pauw B; de Witte T
Leukemia; 2002 Jan; 16(1):13-21. PubMed ID: 11840258
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of chimerism status assessed by lineage-specific short tandem repeat analysis: experience from four cases of allogeneic stem cell transplantation.
Goh RY; Cho SS; Song YJ; Heo K; Oh SY; Kim SH; Kwon HC; Kim HJ; Han JY
Korean J Lab Med; 2009 Aug; 29(4):277-81. PubMed ID: 19726887
[TBL] [Abstract][Full Text] [Related]
31. [First report on assessment of the status of engraftment after allogeneic hematopoietic stem cell transplantation by using denaturing high-performance liquid chromatography].
Wang Y; Pan KF; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):9-15. PubMed ID: 15748427
[TBL] [Abstract][Full Text] [Related]
32. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation].
Chen BA; Xiong HX; Ding JH; Su EB; Zhao G; Wang J; Gao C; Sun YY; Cheng J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):313-7. PubMed ID: 16638205
[TBL] [Abstract][Full Text] [Related]
34. Serial perioperative cell-free DNA levels in donors and recipients undergoing living donor liver transplantation.
Prakash K; Aggarwal S; Bhardwaj S; Ramakrishna G; Pandey CK
Acta Anaesthesiol Scand; 2017 Oct; 61(9):1084-1094. PubMed ID: 28766696
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
36. T-cell chimerism prior to graft-versus-host disease.
Noguchi M; Shindo T; Yamada Y; Date H
Eur J Cardiothorac Surg; 2021 Jul; 60(1):194-196. PubMed ID: 33495782
[TBL] [Abstract][Full Text] [Related]
37. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
[TBL] [Abstract][Full Text] [Related]
38. Evaluating hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation with microsatellites.
Ren Y; Zhu P; Xiao M; Et Al
Zhonghua Nei Ke Za Zhi; 2002 Jul; 41(7):462-4. PubMed ID: 12189116
[TBL] [Abstract][Full Text] [Related]
39. Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.
Taimur S; Askar M; Sobecks R; Rybicki L; Warshawsky I; Mossad S
Transpl Infect Dis; 2014 Feb; 16(1):61-6. PubMed ID: 24251680
[TBL] [Abstract][Full Text] [Related]
40. Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
Blau IW; Schmidt-Hieber M; Leschinger N; Göldner H; Knauf W; Hopfenmüller W; Thiel E; Blau O
Ann Hematol; 2007 Aug; 86(8):583-9. PubMed ID: 17468869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
